Skip to search formSkip to main contentSkip to account menu

Cholera Vaccine

Known as: Cholera vaccines, Vaccines, Cholera, vaccine cholera 
Vaccines or candidate vaccines used to prevent infection with VIBRIO CHOLERAE. The original cholera vaccine consisted of killed bacteria, but other… 
National Institutes of Health

Related topics

Related topics

16 relations

Broader (1)

Bacterial Vaccines
CholeraIn BloodProcess of secretionVaccination against cholera

Narrower (5)

DukoralPeru 15Vaxchoracholera vaccine CVD 103-HgR

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1998
Highly Cited
1998
Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
Mucosal tissues are major sites of HIV entry and initial infection. Thus, the induction of a mucosal cytotoxic T lymphocyte (CTL… 
Highly Cited
1995
Highly Cited
1995
Atomic force microscopy of cholera toxin B-oligomers bound to bilayers of biologically relevant lipids.
Cholera toxin B-oligomer was imaged by atomic force microscopy (AFM) on biologically relevant model membranes, such as 1… 
Highly Cited
1990
Highly Cited
1990
Nomenclature for factors of the HLA system, 1989.
Highly Cited
1987
Highly Cited
1987
Combined oral/nasal immunization protects mice from Sendai virus infection.
Based on the concept of a common mucosal immune system wherein mucosal associated lymphocytes traffic among the various mucous… 
Highly Cited
1986
Highly Cited
1986
Hormone-stimulated polyphosphoinositide breakdown in rat liver plasma membranes. Roles of guanine nucleotides and calcium.
Calcium-sensitive inositide release in a purified rat liver plasma membrane preparation is increased by calcium-mobilizing… 
Highly Cited
1984
Highly Cited
1984
Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
Mucosal and systemic immune responses to a new oral cholera vaccine, consisting of the B subunit plus killed vibrios, were… 
Highly Cited
1984
Highly Cited
1984
Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates
An ideal vacine does not yet exist to prevent cholera, a significant health problem in many less developed countries. Vibrio… 
Highly Cited
1979
Highly Cited
1979
Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
Highly Cited
1978
Highly Cited
1978
Genetic evidence that cholera toxin substrates are regulatory components of adenylate cyclase.
Cholera toxin, using [32P]NAD+ as substrate, specifically radiolabels at least two proteins in plasma membranes of wild type S49… 
Highly Cited
1947
Highly Cited
1947
Use of Trypsin in the Detection of Incomplete Anti-Rh Antibodies
IN an attempt to define the properties of the enzyme present in the filtrate of a culture of vibrio cholera, which causes cells… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)